Viral Threats Research
Abstract
This effort designs and laboratory tests new vaccine candidates against hemorrhagic fever viruses, i.e. Dengue Virus, Hantaviruses Lassa fever Virus and Crimean-Congo hemorrhagic fever virus, and assesses other non-vaccine technologies to protect against hemorrhagic fever viruses. Efforts also include establishing and maintaining of clinical trial sites worldwide.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2017
- Source ID
- 9a293bcf415464faf37474b7d463c931
Related Documents
- Root: Medical Technology